NanoViricides, Inc. (NNVC) compared with its closest peers (ACTU, IGC, LTRN, DARE, BYSI). Peer set by Business model: Biotech (Clinical / Commercial-Stage); 10 closest by market cap; US-domiciled. First-party data.
| Company | Market Cap | P/E |
|---|---|---|
| Actuate Therapeutics Inc (ACTU) | $32.54M | -5.8 |
| IGC Pharma, Inc. (IGC) | $31.49M | -5.6 |
| Lantern Pharma Inc. (LTRN) | $30.17M | -1.9 |
| Daré Bioscience, Inc. (DARE) | $29.74M | -1.6 |
| BeyondSpring Inc. (BYSI) | $29.61M | -80.0 |
| NextCure, Inc. (NXTC) | $29.16M | -0.7 |
| Optimi Health Corp. (OPTH) | $27.43M | — |
| BioXcel Therapeutics, Inc. (BTAI) | $25.35M | -0.3 |
| Atossa Therapeutics, Inc. (ATOS) | $25.30M | -0.1 |
| Aytu BioPharma, Inc. (AYTU) | $25.12M | -1.0 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.0 |
NNVC overview · NNVC earnings · NNVC financials · NNVC KPIs · NNVC investor relations · NNVC ownership · NNVC filings
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.